Leader Biomedical introduces new Spine Portfolio with the launch of three targeted therapeutic solutions Adcon® Gel, Hyalosyn™ Gel, and Vebropl...
Leader Biomedical is pleased to announce the phased acquisition of International Orthopaedics Holding GmbH (International Orthopaedics), a manu...
To better meet the need for biocompatible grafts with good osteoconductive properties, Leader Biomedical has launched the OssGro® range of synt...
Leader Biomedical Group has forged an equity alliance with BioTiss GmbH, which will consolidate human musculoskeletal tissue processing at thei...